Net Cash Provided by (Used in) Financing Activities of IRADIMED CORP from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IRADIMED CORP annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • IRADIMED CORP Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $2,277,819, a 72% increase year-over-year.
  • IRADIMED CORP annual Net Cash Provided by (Used in) Financing Activities for 2025 was $17,601,000, a 23% decline from 2024.
  • IRADIMED CORP annual Net Cash Provided by (Used in) Financing Activities for 2024 was $14,336,000, a 5% decline from 2023.
  • IRADIMED CORP annual Net Cash Provided by (Used in) Financing Activities for 2023 was $13,656,511, a 7.5% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

IRADIMED CORP Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $17,601,000 -$3,265,000 -23% 01 Jan 2025 31 Dec 2025 10-K 06 Mar 2026 2025 FY
2024 $14,336,000 -$679,489 -5% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2026 2025 FY
2023 $13,656,511 -$950,111 -7.5% 01 Jan 2023 31 Dec 2023 10-K/A 03 Sep 2025 2024 FY
2022 $12,706,400 -$12,730,825 -52122% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2024 2023 FY
2021 $24,425 -$498,057 -95% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $522,482 -$1,497,690 -74% 01 Jan 2020 31 Dec 2020 10-K 04 Mar 2022 2021 FY
2019 $2,020,172 +$1,090,298 +117% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2022 2021 FY
2018 $929,874 +$2,830,189 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2021 2020 FY
2017 $1,900,315 +$7,218,467 +79% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2020 2019 FY
2016 $9,118,782 -$11,444,885 -492% 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019 2018 FY
2015 $2,326,103 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018 2017 FY

IRADIMED CORP Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,277,819 +$5,762,054 +72% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q1 2024 $8,039,873 +$5,232,910 +39% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q1 2023 $13,272,783 -$718,224 -5.7% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $12,554,559 -$12,518,312 -34536% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $36,247 -$224,554 -119% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $188,307 -$245,925 -57% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $434,232 +$342,684 +374% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $91,548 +$102,415 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $10,867 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.